02181.HK
Mabpharm Limited
HKSE · Healthcare · Biotechnology · CN
HKD 0.45
+0.00%Leverage
- Debt / equity
- 2.08x
- Net debt / equity
- 1.38x
- Debt / assets
- 0.28x
- Debt / EBITDA
- -51.01x
- Net debt / EBITDA
- -33.96x
Liquidity & coverage
- Current ratio
- 0.81x
- Quick ratio
- 0.56x
- Cash ratio
- 0.20x
- Interest coverage
- -5.42x
- EBITDA / interest
- -0.30x
- Working capital
- -HKD 116.3M
Cash & dividend
- FCF / debt
- -0.16x
- Cash flow / debt
- 0.23x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025